Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07724847) titled 'Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis' on July 21.

Study Type: Observational [Patient Registry]

Primary Sponsor: Chinese PLA General Hospital

Condition: Axial Spondyloarthritis (AxSpA) Spondyloarthritis (SpA) Chronic Back Pain

Intervention: Other: Diagnostic Assessment

Recruitment Status: Recruiting

Date of First Enrollment: April 10, 2026

Target Sample Size: 247

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07724847

Published by HT Digital Content Services with permission from Health Daily Digest....